MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
15.00
NaN%
Opening 09:30 09/30 EDT
OPEN
--
PREV CLOSE
14.75
HIGH
--
LOW
--
VOLUME
--
TURNOVER
15
52 WEEK HIGH
39.03
52 WEEK LOW
25.42
MARKET CAP
26.90B
P/E (TTM)
11.88
1D
5D
1M
3M
1Y
5Y
1D
Astellas Pharma (ALPMF) Gets a Sell from Daiwa
TipRanks · 6h ago
Weekly Report: what happened at ALPMF last week (0921-0925)?
Weekly Report · 2d ago
Weekly Report: what happened at ALPMF last week (0914-0918)?
Weekly Report · 09/21 09:49
Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer
Benzinga · 09/18 16:45
Mizuho Securities Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 09/14 10:15
Weekly Report: what happened at ALPMF last week (0907-0911)?
Weekly Report · 09/14 09:52
Weekly Report: what happened at ALPMF last week (0831-0904)?
Weekly Report · 09/07 09:48
Trump unveils new drug-pricing accords with CSL, Astellas, and other biotech drugmakers
Seeking Alpha · 09/01 04:10
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.